Abstract submission is open
Abstract Submission Deadlines
All abstract submissions for an ESMO Virtual Plenary must be completed by 12:00hrs Swiss time on the dates listed below:
Abstract submission deadline |
Virtual Plenary presentation |
|---|---|
Friday, 11 November 2022 |
Thursday, 15 December 2022 |
Friday, 13 January 2023 |
Thursday, 16 February 2023 |
Friday, 10 February 2023 |
Monday, 27 March 2023 |
Friday, 7 April 2023 |
Thursday, 11 May 2023 |
Friday, 12 May 2023 |
Thursday, 15 June 2023 |
Friday, 9 June 2023 |
Thursday, 13 July 2023 |
Friday, 11 August 2023 |
Thursday, 14 September 2023 |
Friday, 13 October 2023 |
Thursday, 16 November 2023 |
Submission Categories
- Basic science
- Biliary tract cancer, incl. cholangiocarcinoma
- Biomarkers (agnostic)
- Breast cancer, early stage
- Breast cancer, locally advanced
- Breast cancer, metastatic
- CNS tumours
- Colorectal cancer
- Developmental therapeutics
- Endocrine tumours
- Germ cell (testicular) cancer and penile cancer
- Gynaecological cancers
- Haematological malignancies
- Head and neck cancer, excluding thyroid
- Hepatocellular carcinoma (HCC)
- Investigational immunotherapy
- Melanoma and other skin tumours
- Miscellaneous
- Neuroendocrine tumours
- New diagnostic tools
- NSCLC, early stage
- NSCLC, locally advanced
- NSCLC, metastatic
- Oesophagogastric cancer
- Palliative care
- Pancreatic cancer
- Policy and preventive strategies
- Prostate cancer
- Psycho-oncology
- Renal cancer
- Sarcoma
- SCLC
- Supportive care
- Thoracic malignancies, other
- Thyroid cancer
- Translational research (agnostic)
- Tumour biology and pathology
- Urothelial cancer
Review and Publication of Accepted Abstracts
Submitted abstracts will be reviewed by the the ESMO Virtual Plenary Review Panel comprising the ESMO President, ESMO President-elect, ESMO Chief Medical Officer, ESMO Congress Scientific Chair(s) and the appropriate Scientific Track Chairs.
Accepted abstracts will be granted an oral presentation by the first author, followed by expert perspectives and an interactive panel and audience discussion / Q&A session.
Presented abstracts will be published in Annals of Oncology as well as on the Annals of Oncology and ESMO websites.